KDR and neoplasm: This possible link, LDH levels and tumor angiogenesis, has been analyzed in 2 different clinical trials (the CONFIRM 1 & 2 trials) investigating PTK/ZK (vatalanib), an oral VEGFR (vascular endothelial growth factor receptor) inhibitor in advanced colorectal cancer.